查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球经前综合症 (PMS) 药物市场 (2022-2030)：增长、未来展望、竞争对手分析
市场调查报告书
商品编码
1182394

全球经前综合症 (PMS) 药物市场 (2022-2030)：增长、未来展望、竞争对手分析

Pre-Menstrual Syndrome Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

由于 PMS 患病率的增加以及对 PMS 和常见治疗方案的认识不断提高，目前经前综合症 (PMS) 药物市场由北美和欧洲主导。. 另一方面，亚太和中东及非洲地区为 PMS 疗法製造商提供了有利可图的机会。 大量的育龄妇女以及不断提高的识字率和工作人口极大地促进了这些地区商业机会的扩大。 此外，越来越多的政府举措和活动以妇女和孕产妇健康为重点，进一步推动了市场增长。

本报告调查了全球经前综合症 (PMS) 药物市场，提供了市场概况、对市场增长的各种影响因素的分析、市场规模、各个细分市场、地区和主要国家的趋势和预测。我们单独编制了一份报告细目分类、主要公司概况等。

内容

第一章前言

第 2 章执行摘要

第 3 章经前综合症 (PMS) 药物市场：竞争分析

  • 供应商在市场中的地位
  • 供应商招聘策略
  • 主要行业战略
  • 等级分析：2021/2030

第 4 章经前综合症 (PMS) 药物市场：宏观分析和市场动态

  • 世界市场规模：2020-2030
  • 市场动态
    • 市场驱动因素
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和製约因素的影响分析
  • 跷跷板分析

第 5 章经前综合症 (PMS) 药物市场：按药物类型分类

  • 市场概览
  • 增长/利润分析：2021/2030
  • 市场分类
    • 止痛药（止痛药）
    • 口服避孕药 (OCP)
    • 促性腺激素释放激素 (GnRH)
    • 抗抑郁药
    • 卵巢抑製剂
    • 利尿剂
    • 苯二氮卓类

第 6 章北美经前综合症 (PMS) 药物市场

  • 市场概览
  • 经前综合症 (PMS) 药物市场：按药物类型分类
  • 经前综合症 (PMS) 药物市场：按地区

第 7 章英国和欧盟的经前综合症 (PMS) 药物市场

  • 市场概览
  • 经前综合症 (PMS) 药物市场：按药物类型分类
  • 经前综合症 (PMS) 药物市场：按地区

第 8 章亚太经前综合症 (PMS) 药物市场

  • 市场概览
  • 经前综合症 (PMS) 药物市场：按药物类型分类
  • 经前综合症 (PMS) 药物市场：按地区

第 9 章。拉丁美洲经前综合症 (PMS) 药物市场

  • 市场概览
  • 经前综合症 (PMS) 药物市场：按药物类型分类
  • 经前综合症 (PMS) 药物市场：按地区

第 10 章中东和非洲的经前综合症 (PMS) 药物市场

  • 市场概览
  • 经前综合症 (PMS) 药物市场：按药物类型分类
  • 经前综合症 (PMS) 药物市场：按地区

第11章公司简介

  • Alva-Amco Pharmacal Cos., Inc.
  • Bayer, Inc.
  • Chattem, Inc.（Sanofi）
  • DEKK-TEC, Inc.
  • G. R. Lane Health Products Ltd
  • McNeil Consumer Healthcare
  • MetP Pharma AG
  • Pherin Pharmaceuticals, Inc.
  • Umecrine Mood AB
  • Umecrine Mood AB
  • Novartis AG
  • GlaxoSmithKline Plc
Product Code: 137381-08-22

Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffer from PMS; and one in every twenty women demonstrate life disturbing symptoms. Pre-menstrual dysphoric disorder (PMDD) is a further severe form of PMS and demonstrates more severe symptoms of PMS, often interfering with social activities, work and emotional balance. PMDD occurs in 3% to 5% of menstruating women. Though the exact cause of PMS is unknown, it is reported that fluctuating levels of hormones (estrogen and progesterone) are related to PMS symptoms. The treatment regimen of PMS is temporary i.e. administered only for symptom management before the onset of menstrual cycle. Education, nutrition, exercise and medication together form the complete layout of PMS treatment module.

The report titled "Pre-menstrual Syndrome Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall pre-menstrual syndrome treatment market along with the market size and estimates for the duration 2020 to 2030. The said research study covers in-depth analysis of multiple market segments based on type of drugs and different geographies. The drug types studied for analyzing the overall global pre-menstrual syndrome treatment market are majorly segmented into analgesics (pain killers), oral contraceptive pills (OCPs), gonadotropin-releasing hormone (GnRH), antidepressants, ovarian suppressors, diuretics and benzodiazepines.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global pre-menstrual syndrome treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global pre-menstrual syndrome treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global pre-menstrual syndrome treatment market. In-depth competitive environment analysis and historical (2020) market size data are also provided in the report.

Common painkillers available for treating PMS are NSAIDS and paracetamol. This segment is majorly dominated by over-the-counter drugs that are cheap and easily available in the market. For depression and anxiety, particularly in patients with PMDD, drugs such as SSRIs (commonly fluoxetine and sertraline) are commonly prescribed. GnRH i.e. synthetic hormones are prescribed to initiate temporary menopause in patients with severe PMS. It is observed that the demand for hormone-based PMS treatments is on a perpetual rise and will continue through the forecast period.

At present, North America and Europe dominate the premenstrual syndrome treatment market due to increase in prevalence of premenstrual syndrome and higher awareness about syndrome and prevailing treatment options. Asia Pacific and Middle East and Africa together present lucrative opportunities to manufacturers offering PMS treatment drugs. Large pool of females in childbearing age, growing literacy rate and working population significantly contribute to growing opportunities in the region. Growing number of government initiatives and campaigns focusing on women and maternity health are further driving the market growth.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pre-Menstrual Syndrome Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Pre-Menstrual Syndrome Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drugs Type

  • Analgesics (pain killers)
  • Oral Contraceptive Pills (OCPs)
  • Gonadotropin-releasing Hormone (GnRH)
  • Antidepressants
  • Ovarian Suppressors
  • Diuretics
  • Benzodiazepines

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Pre-Menstrual Syndrome Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Pre-Menstrual Syndrome Treatment market?
  • Which is the largest regional market for Pre-Menstrual Syndrome Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Pre-Menstrual Syndrome Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Pre-Menstrual Syndrome Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Pre-Menstrual Syndrome Treatment Market
  • 2.2. Global Pre-Menstrual Syndrome Treatment Market, By Drugs Type, 2021 (US$ Million)
  • 2.3. Global Pre-Menstrual Syndrome Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Pre-Menstrual Syndrome Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Pre-Menstrual Syndrome Treatment Market Vendors
  • 3.2. Strategies Adopted by Pre-Menstrual Syndrome Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Pre-Menstrual Syndrome Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Pre-Menstrual Syndrome Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Analgesics (pain killers)
    • 5.3.2. Oral Contraceptive Pills (OCPs)
    • 5.3.3. Gonadotropin-releasing Hormone (GnRH)
    • 5.3.4. Antidepressants
    • 5.3.5. Ovarian Suppressors
    • 5.3.6. Diuretics
    • 5.3.7. Benzodiazepines

6. North America Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 6.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

7. UK and European Union Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 7.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

8. Asia Pacific Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 8.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

9. Latin America Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 9.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

10. Middle East and Africa Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 10.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Alva-Amco Pharmacal Cos., Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Bayer, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Chattem, Inc. (Sanofi)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. DEKK-TEC, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. G. R. Lane Health Products Ltd
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. McNeil Consumer Healthcare
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. MetP Pharma AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Pherin Pharmaceuticals, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Umecrine Mood AB
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Umecrine Mood AB
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Novartis AG
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. GlaxoSmithKline Plc
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 2 North America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 3 U.S. Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 4 Canada Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 5 Rest of North America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 7 UK Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 8 Germany Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 9 Spain Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 10 Italy Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 11 France Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 12 Rest of Europe Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 13 Asia Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 14 China Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 15 Japan Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 16 India Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 17 Australia Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 18 South Korea Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 19 Latin America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 20 Brazil Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 21 Mexico Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 22 Rest of Latin America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 23 Middle East and Africa Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 24 GCC Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 25 Africa Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 26 Rest of Middle East and Africa Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Pre-Menstrual Syndrome Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Pre-Menstrual Syndrome Treatment Market: Quality Assurance
  • FIG. 5 Global Pre-Menstrual Syndrome Treatment Market, By Drugs Type, 2021
  • FIG. 6 Global Pre-Menstrual Syndrome Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Pre-Menstrual Syndrome Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Pre-Menstrual Syndrome Treatment Market Players, 2021
  • FIG. 9 Global Pre-Menstrual Syndrome Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Pre-Menstrual Syndrome Treatment Market, By Drugs Type, 2021 Vs 2030, %
  • FIG. 11 U.S. Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030